SOM Biotech appoints George G. Montgomery as Strategic Corporate Advisor

posted on May 28, 2024

SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligent platform, has appointed George G. Montgomery as Strategic Corporate Advisor to the Board.

Press Release: SOM Biotech appoints George G. Montgomery as Strategic Corporate Advisor